Sigma Healthcare Company Profile and Share Price History

Sigma Healthcare is a leading Australian pharmacy services company that has been in operation since 2004. It was founded by the merger of Sigma Pharmaceutical and Healthcare Logistics.

The company has a strong presence in the Australian market, with over 1,000 pharmacies across the country. This extensive network allows Sigma to provide a wide range of services to its customers.

Sigma Healthcare's share price has experienced fluctuations over the years, with a peak in 2007 and a low in 2013. The company's market value is significant, with a total equity of over $1 billion.

Sigma's focus on delivering quality healthcare services has contributed to its success and growth in the market.

Sigma Healthcare's financial performance has been a remarkable story over the past few years.

The company reported a net profit after tax of $59,761,000 for the year ended January 31, 2021, a significant jump from the prior period's loss of $12,330,000.

Sigma Healthcare's sales revenue has been steadily increasing, from $3,400,379 in 2021 to $4,841,201 in 2025.

Here's a breakdown of the company's revenue growth:

The company's reported earnings before interest, tax, depreciation, and amortisation (EBITDA) of $94,198,000 in 2021 was a 289.2% increase from the prior period's $24,200,000.

Sigma Healthcare's financial performance is a testament to the company's ability to adapt and grow in a rapidly changing market.

Sigma Healthcare Limited operates in a competitive market, with its financial ratios and growth comparable to those of its peers.

The company's industry is characterized by a mix of market leaders and smaller players, with Sigma Healthcare Limited holding a significant market share.

To gain a clearer picture of Sigma Healthcare Limited's performance, it's essential to compare its financial ratios and growth to those of its peers in the industry.

Sigma Healthcare Limited's competitors in the industry are likely to be larger companies, but the company's ability to adapt to changing market conditions has allowed it to maintain a strong market presence.

In the competitive environment, Sigma Healthcare Limited's financial performance is worth comparing to its peers in the industry.

Sigma Healthcare Limited's financial ratios and growth can be compared to other companies in its industry, giving a clearer picture of its performance.

BHP Group Limited operates in multiple industries, including mining and metals.

BHP Group Limited's market share breakdowns reveal that it has a significant presence in these industries.

Key industry insights for BHP Group Limited's industries of operation include market trends, customer needs, and competitor activity.

Understanding the competitive environment is crucial for businesses to stay ahead in the market.

By analyzing industry benchmarks and market share, businesses can identify areas for improvement and develop strategies to gain a competitive edge.

Intriguing read: Do Businesses Prefer Cash or Credit

Sigma Healthcare Ltd has a clear go-to-market proposition, which is evident in its clinical operations.

The company's clinical operations are a crucial part of its overall strategy, and understanding them is essential for anyone looking to work with Sigma Healthcare Ltd.

Intriguing read: Bcbs Clinical Appeal Form

Sigma Healthcare Ltd's clinical operations involve conducting clinical trials to test the efficacy and safety of its products.

Recruitment is a key aspect of clinical trials, and Sigma Healthcare Ltd has a robust recruitment strategy in place.

The company's trial strategy is designed to ensure that its clinical trials are conducted efficiently and effectively, with minimal disruption to its operations.

Sigma Healthcare Ltd's clinical operations are a testament to its commitment to delivering high-quality products to its customers.

Sigma Healthcare Ltd has a commercialized product portfolio that's worth taking a closer look at to stay ahead of the market.

Their marketed drugs are a key part of this portfolio, offering a range of products that cater to different patient needs.

Sigma Healthcare Ltd understands the importance of having a diverse product portfolio to meet the evolving needs of the market.

This is reflected in their marketed drugs, which are designed to address specific health conditions and improve patient outcomes.

Sigma Healthcare Ltd's marketed drugs are a testament to their commitment to delivering high-quality products that make a real difference in people's lives.

If this caught your attention, see: Special Needs Trust Trustee

Sigma Healthcare's Mergers and Acquisitions have been a defining feature of the company's evolution over the years. In 2010, the company sold its generic drug manufacturing business to Aspen Pharmacare for AUD$804 million.

Sigma has been actively acquiring businesses to expand its reach and capabilities. In 2014, the company acquired Central Healthcare Services for $24.5 million and the Discount Drug Store (DDS) banner for $26.7 million.

The acquisition of Medication Packaging Systems (MPS) in 2017 marked a significant diversification for Sigma, allowing it to tap into the aged care sector and community pharmacy patients. This move was partly in response to changes in pharmacists' payments under the Pharmaceutical Benefits Scheme.

Sigma's retail pharmacy business has also undergone significant changes. In 2020, the company sold its land and buildings of distribution centres in Queensland and New South Wales, but leased them back for an initial term of 15 years.

The company's bid to acquire Australian Pharmaceutical Industries (API) in 2021 was worth AUD$773.5 million, but was withdrawn after Wesfarmers announced its purchase of 19.3% of API's shares.

Sigma's focus on consolidation and franchise growth continues, with the company announcing plans to consolidate its retail brands under the Amcal and Discount Drug Store brands in 2022. This move is part of the company's long-term strategy to strengthen its position in the market.

A fresh viewpoint: Ohio E Check Years

Sigma Healthcare has a diverse group of shareholders, with no single entity holding a majority of the company's shares. The largest shareholder, HSBC Custody Nominees (Australia) Limited, holds 14.61% of the company's capital.

Several institutional investors are among the top shareholders, including J P Morgan Nominees Australia Pty Limited, Citicorp Nominees Pty Limited, and Bond Street Custodians Limited. These investors hold significant stakes in the company, with J P Morgan Nominees Australia Pty Limited holding 6.03% of the company's capital.

The company also has a number of smaller shareholders, including individual investors and family foundations. The Dgsr Family Foundation Pty Ltd and Av Family Foundation Pty Ltd are two examples of family foundations that hold significant stakes in the company, with 5.93% and 5.26% of the company's capital, respectively.

Here is a list of the top 10 shareholders of Sigma Healthcare, based on the number of shares held:

Sigma Healthcare, a leading pharmacy and healthcare business, has been making headlines in recent times. They acquired the pharmacy business of Symbion in 2014.

Sigma Healthcare has been expanding its services, with the acquisition of Guardian Health & Beauty in 2017.

Sigma Healthcare has been expanding its services, with the acquisition of Guardian Health & Beauty in 2017.

In 2019, Sigma Healthcare was acquired by a consortium of investors, led by BGH Capital.

Broaden your view: Health Saving Account Contribution Limit 2017

Sigma Healthcare's shares have seen a remarkable surge, increasing by 113% in just one year. This impressive growth has left many investors wondering if the stock is still a good buy.

The question on everyone's mind is whether this upward trend will continue. A leading expert has weighed in on the outlook for Sigma Healthcare's shares, offering valuable insights for potential investors.

The expert's verdict is crucial in determining the future prospects of the company.

Related reading: Sec Rule 15c2-11 Otc Expert Market

Sigma Healthcare shares have soared more than 100% in the past year. That's a remarkable increase, and it's natural to wonder if the trend will continue.

JP Morgan has initiated coverage on Sigma Healthcare shares with an overweight rating. This suggests that the analysts at JP Morgan believe the stock has significant potential for growth.

Sigma Healthcare has poached an experienced executive to be its new chief financial officer. This move could bring valuable expertise and stability to the company.

The Sigma Healthcare share price has jumped more than 7% on Wednesday, and it's up 113% in a year. These numbers are a testament to the company's strong performance.

The share price of SIG has been steadily fluctuating over the past few weeks, with some notable changes.

On 02 Oct 2025, the share price reached $3.01, a 1.35% increase from the previous day.

Looking at the daily volume, we can see that on 02 Oct 2025, it was 28,730,967, which is significantly higher than the average volume.

A closer look at the data shows that on 19 Sep 2025, the share price experienced a 2.37% increase to $3.02.

The share price has also experienced some significant declines, such as on 18 Sep 2025, when it dropped to $2.95, a 1.01% decrease from the previous day.

Here is a summary of the share price changes over the past few weeks:

The share price has been relatively stable over the past few days, with some minor fluctuations.

The ACCC's decision to approve the proposed merger between Sigma Healthcare and Chemist Warehouse is a critical milestone for the company.

Sigma Healthcare CEO Vikesh Ramsunder described the decision as a "critical milestone" for the company.

The proposed merger has the potential to create a leading ASX listed healthcare company through the combination of Sigma's state-of-the-art pharmaceutical distribution infrastructure with Chemist Warehouse Group's retailing know-how.

Sigma would acquire all of Chemist Warehouse's shares in exchange for all of Sigma's shares and $700 million.

The deal still needs to be approved by Sigma Healthcare and Chemist Warehouse's respective shareholders before being finalized.

Sigma's share price surged by more than 27 per cent during trade on Wednesday morning after the ACCC's announcement.

To get a comprehensive understanding of Sigma Healthcare, you can access their enterprise profile, which includes a detailed history and synopsis of the company.

IBISWorld provides expert reports that are thoroughly researched, reliable, and current.

Sigma Healthcare's enterprise profile features an overview of their brands and products, giving you a clear picture of their offerings.

On a similar theme: Risk Taker Ib Learner Profile

The profile also includes financial statements and financial ratios, which are essential for making informed business decisions.

Key personnel at Sigma Healthcare are also listed in their enterprise profile, providing valuable insights into the company's leadership structure.

Sigma Healthcare's subsidiaries, shareholders, and ownership structure are all detailed in their profile, helping you understand their business relationships.

Their service providers are also listed, giving you a sense of the company's partnerships and collaborations.

Here is a summary of the information you can find in Sigma Healthcare's enterprise profile: